Coinbase CEO’s Biotech Firm Gets $130M to Fight Aging With AI, Genomics – Decrypt

vm_admin
Coinbase CEO’s Biotech Firm Gets 0M to Fight Aging With AI, Genomics – Decrypt

In brief

  • NewLimit aims to increase healthy lifespan using AI-driven cell reprogramming.
  • The Series B round brings total funding to over $170 million, backed by top tech and VC names.
  • The longevity startup is part of a broader trend of billionaire-backed longevity ventures.

NewLimit, a biotechnology startup co-founded by Coinbase CEO Brian Armstrong, has raised $130 million in a Series B funding round to bolster its ambitions to slow or even reverse aspects of human aging.

The round, led by…

Article Source
https://decrypt.co/318262/coinbase-ceos-biotech-firm-gets-130m-to-fight-aging-with-ai-genomics

Related Posts